查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1317911

药物研发发现外包市场：按工作流程、治疗领域、类型和最终用户划分 - 2023-2030 年全球预测

Drug Discovery Outsourcing Market by Workflow, Therapeutics Area, Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药物研发发现外包市场预计将大幅成长，预计2023年将达到401864万美元，年复合成长率为9.32%，2030年将达到惊人的753299万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球药物研发外包市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.药物研发发现外包的全球市场规模与预测为何？

2. 在预测期内，COVID-19 对全球药物研发发现外包市场的阻碍因素和影响是什么？

3. 在预测期内，全球药物研发发现外包市场需要投资哪些产品/细分市场/应用/领域？

4.全球药物研发发现外包市场的竞争策略为何？

5. 全球药物研发发现外包市场的技术趋势和法律规范是什么？

6.全球药物研发发现外包市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入全球药物研发发现外包市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 各种慢性病盛行率上升以及医疗费用上涨
      • 加大医药研发投入
      • 对仿製药和生物创新的需求不断增长
    • 抑制因素
      • 外包时的合规问题
    • 机会
      • 个人化医疗日益受到关注
      • 增加生物製品管道数量并扩大合约製造服务
    • 任务
      • 严格的政府法规
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章发现外包市场：依工作流程

  • 潜在客户识别和候选最佳化
  • 临床前开发
  • 目标识别和筛选
  • 目标检验和功能资讯

第7章依治疗领域分類的药物发现外包市场

  • 抗感染疾病
  • 心血管
  • 中枢神经系统
  • 皮肤科
  • 内分泌
  • 胃
  • 泌尿器官系统
  • 血液学
  • 免疫调节
  • 肿瘤学
  • 眼科
  • 疼痛和麻醉
  • 呼吸系统

第8章发现外包市场：按类型

  • 生物服务
  • 化学服务

第9章发现外包市场：依最终用户分类

  • 学术机构
  • 製药和生物技术公司

第10章美洲药物研发发现外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太药物研发发现外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲药物研发外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-742BD517D94F

The Global Drug Discovery Outsourcing Market is forecasted to grow significantly, with a projected USD 4,018.64 million in 2023 at a CAGR of 9.32% and expected to reach a staggering USD 7,532.99 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Discovery Outsourcing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Discovery Outsourcing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Workflow, market is studied across Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening, and Target Validation & Functional Informatics. The Target Validation & Functional Informatics is projected to witness significant market share during forecast period.

Based on Therapeutics Area, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Dermatology, Endocrine, Gastrointestinal, Genitourinary System, Hematology, Immunomodulation, Oncology, Ophthalmology, Pain & Anesthesia, and Respiratory System. The Dermatology is projected to witness significant market share during forecast period.

Based on Type, market is studied across Biology Services and Chemistry Services. The Chemistry Services is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Academic Institutes and Pharmaceutical & Biotechnology companies. The Pharmaceutical & Biotechnology companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Discovery Outsourcing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Outsourcing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Outsourcing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Outsourcing Market?

4. What is the competitive strategic window for opportunities in the Global Drug Discovery Outsourcing Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Outsourcing Market?

6. What is the market share of the leading vendors in the Global Drug Discovery Outsourcing Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Outsourcing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Discovery Outsourcing Market, by Workflow, 2022 vs 2030
  • 4.3. Drug Discovery Outsourcing Market, by Therapeutics Area, 2022 vs 2030
  • 4.4. Drug Discovery Outsourcing Market, by Type, 2022 vs 2030
  • 4.5. Drug Discovery Outsourcing Market, by End-User, 2022 vs 2030
  • 4.6. Drug Discovery Outsourcing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
      • 5.1.1.2. Increasing pharmaceutical R&D investment
      • 5.1.1.3. Rising demand for generic drugs and biologic innovation
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues while outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased focus on personalized medicine
      • 5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Discovery Outsourcing Market, by Workflow

  • 6.1. Introduction
  • 6.2. Lead Identification & Candidate Optimization
  • 6.3. Preclinical Development
  • 6.4. Target Identification & Screening
  • 6.5. Target Validation & Functional Informatics

7. Drug Discovery Outsourcing Market, by Therapeutics Area

  • 7.1. Introduction
  • 7.2. Anti-Infective
  • 7.3. Cardiovascular
  • 7.4. Central Nervous System
  • 7.5. Dermatology
  • 7.6. Endocrine
  • 7.7. Gastrointestinal
  • 7.8. Genitourinary System
  • 7.9. Hematology
  • 7.10. Immunomodulation
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Pain & Anesthesia
  • 7.14. Respiratory System

8. Drug Discovery Outsourcing Market, by Type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Outsourcing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Pharmaceutical & Biotechnology companies

10. Americas Drug Discovery Outsourcing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Outsourcing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Outsourcing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
  • FIGURE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENITOURINARY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESPIRATORY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 198. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 199. DRUG DISCOVERY OUTSOURCING MARKET LICENSE & PRICING